Amoxapine
Talk0this wiki
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology
|
Amoxapine chemical structure | |
| IUPAC name | |
| CAS number 14028-44-5 | ATC code |
| PubChem 2170 | DrugBank APRD00142 |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 313.781 |
| Bioavailability | ? |
| Metabolism | Hepatic (cytochrome P450 system) |
| Elimination half-life | 8-10 hours (30 hours for major metabolites) |
| Excretion | Renal |
| Pregnancy category | {{{pregnancy_category}}} |
| Legal status | {{{legal_status}}} |
| Routes of administration | Oral |
Amoxapine (brand-names Asendin®, Asendis®, Defanyl®, Demolox®, Moxadil®) is a tetracyclic antidepressant of the dibenzoxazepine class. It is used in the treatment of depression, panic disorders and bipolar disorder.
Amoxapine is a strong reuptake inhibitor of norepinephrine and weak reuptake inhibitor of serotonin. One of its major metabolites, 7-hydroxyamoxapine, has a dopamine receptor blocking effect.
References
- Mosby Year-Book, Inc. (1995). Physician's GenRx: The Complete Drug Reference (5th Ed.). Riverside, CT: Denniston Publishing Co.
- Palfai, T. & Jankiewicz, H. (1997). Drugs and Human Behavior (2nd Ed.). Madison, WI: Brown & Benchmark.
- Hedges, D. & Burchfield, C. (2006). Mind, Brain, and Drug: An Introduction to Psychopharmacology. Boston, MA: Pearson.
- fr:Amoxapine
- ja:アモキサピン
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |